We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avingtrans Plc | LSE:AVG | London | Ordinary Share | GB0009188797 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 375.00 | 370.00 | 380.00 | 375.00 | 375.00 | 375.00 | 0.00 | 08:00:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Engineering Services | 136.62M | 3.65M | 0.1108 | 33.84 | 123.37M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/4/2021 10:56 | Nice rise this am | ayl30 | |
12/4/2021 16:25 | I am going on the basis that JTC as per today's holdings RNS are taking over the RBC role. | cerrito | |
09/4/2021 09:05 | Good that RBC have been able to exit more than 6pc of the shares without moving the price given the illiquidity in AVG shares | cerrito | |
30/3/2021 11:12 | Getting close now - move above 330 and that will be an all time high... just a matter of time! | strollingmolby | |
29/3/2021 21:51 | Hopefully this will give it a bit of needed publicity | ayl30 | |
29/3/2021 20:40 | Simon Thomson The holding has produced a total return of 60 per cent to date and I see further upside to my upgraded sum-of-the-parts valuation of 400p a share, the equivalent of a 2021-22 cash-adjusted price/earnings (PE) ratio of 15. Buy. | cockerhoop | |
12/3/2021 07:52 | Was only looking at the Peter Brotherhood results this week at Companies House. Pretty decent outcome considering Hayward Tyler bought Peter Brotherhood for approx £10m and then completed a sale and leaseback of the Peterborough site for £7.5m. | cockerhoop | |
12/3/2021 07:22 | The Peter Brotherhood salr seems good news for all concerned. | cerrito | |
12/3/2021 07:19 | Wow, what a good deal that was only 3 and a half years ago. 4x gross return. ST looks right again on valuing on a sum of the parts. No doubt he will update again on Monday. This is turning into a mini Melrose for its ability to spot the deals. | 18bt | |
22/2/2021 10:17 | Tipped by Simon Thompson in the IC On this basis, the shares are rated on a reasonable price/earnings (PE) ratio of 15.5 and offer a prospective dividend yield of 1.3 per cent. However, any asset disposals are likely to command a much higher exit earnings multiple, which is why I am upgrading my sum-of-the-parts valuation to 375p-a-share, the equivalent of a 2021/22 PE ratio of 17. Buy | cockerhoop | |
10/2/2021 18:12 | Alter, it's probably just some pullback after a decent recent run. Fundamentals unchanged for me - it's a bit of a sleeper and one day we'll wake up to them doing a big deal to sell the MRI or metal working business for a great price, just like they did for Aerospace some years back. Or at least that's my hope! | cisk | |
10/2/2021 17:28 | Investor's Champion "...forecast earnings multiple of 14x (share price 301p), which looks quite full for an engineering business like this." | energeticbacker | |
10/2/2021 15:41 | Well I thought these were very respectable results. Somewhat disappointed to see the fall back in share price but I guess the market wants more excitement, not competence and patient management of the business. "Avingtrans continues to make good progress during the pandemic and has proven to be resilient. Following our PIE strategy, both Booth Industries and Energy Steel are continuing to improve since acquisition and the potentially transformational deal with Magnetica (post period end) is an exciting prospect for the medical division. The period result shows improving profits against flat revenues, once more demonstrating our agility, even in adversity." | alter ego | |
11/1/2021 22:36 | Regards Luton I'm not sure in the interview if CM was talking gross or net after financing a new green field site. £20m doesn't seem massive for a site capable of 1000 homes. Could have a £200m potential total project value. Regards the Medtech JV. Magnetica have developed an extremity MRI scanner (arms, legs, etc). Much smaller than a full body MRI. They had another JV partner who (surprisingly according to Magnetica) pulled out after the product had been developed but prior being marketed etc. AVG have stepped in with that funding and combined the 3 businesses. | cockerhoop | |
11/1/2021 20:19 | I have seen figures quoted of between £15m & £30m that seems to confirm the figure quoted by Christopher Mills. Anyone have any thoughts as to what the JV might be about? it seems that Scientific Magnets & Tecmag being wound into the JV gives AVG 60% of the project but yet the Meditech name is the one going forward. That said the Board decisions in the past have always proved to be correct with hindsight therefore I await developments with interest!! | dgwinterbottom | |
11/1/2021 18:01 | Christopher Mills suggested in November that it was over £20m having bought a fair chunk of Nigel Wrays stake (hinting at CGT planning). There's also been no mention on here of the recent Magnetica JV which looks to complete the circle of the MRI business with a mobile MRI extremity scanner ready to market. The incremental investments AVG making suggest the JV valued around £50m with AVG stake around £30m. | cockerhoop | |
11/1/2021 16:12 | Has anyone got any idea what that Luton site is worth? | arthur_lame_stocks | |
27/11/2020 13:17 | Solid group of businesses run by smart people. Some good new shareholders aboard who bought Nigel Wray's shares. I sense a new high for Avingtrans in the year ahead. | westofengland | |
27/11/2020 11:51 | So a month on since Nigel Wray waved goodbye and it would appear has done no harm to the share price with a rise of just shy of 10% since then. Slowly but surely we are working our way back to an share price of 300p, not seen since the Covid fall. I wonder if this figure represents being overpriced or future potential built in, my problem being I have never found a formula for calculation of share price from Annual Reports etc. The highest the share price climbed to before the pandemic was 330p perhaps reflecting the niche - nuclear - that the Group operates in. Interesting times!! | dgwinterbottom | |
23/10/2020 11:48 | I suggest the other trades are some of the buyers of Nigel Wray's stock. I guess we will hear who these are once the trades have settled. Then we csn take a view on the situation.Unlikely to be any issues given the speed at which the stock was placed. | westofengland | |
23/10/2020 09:05 | So, Nigel Wray has left Avingtrans after many years, with at one time if I remember correctly about 15% of the company, no doubt he has done well, at one time the shares were as low as 20p. Whilst he has placed his 3.24m shares in a placing there have also been two other large sells, one of 1.07m and the other of 1.73m both within two minutes of the Nigel Wray placing. Therefore a total of 6.04 shares have been placed in the market or approx 18% of issued share, I wonder what may be the reason for these significant sells? | dgwinterbottom | |
02/10/2020 20:54 | I have held shares in AVG since the Haywatd Tyler takeover. It is a well managed business and I added twice earlier thia year. The Booth acquisition is a winner. A great play on nuclear power servicing and a beneficiary of higher infrastructure spend in UK and US. Glad that there's the prospect of a dividend return next year together with potential deals during a difficult time for potential targets. | westofengland | |
01/10/2020 11:47 | Tipped by Simon Thompson in the IC today. | value hound | |
30/9/2020 09:06 | Avingtrans has secured a multi-year contract worth £36m to supply cross passage doors for the HS2 rail link. Most of the revenues for this contract will be generated when the door manufacturing and installation begins in 2025 with a project completion date of 2030. The assets of Booth were acquired in July 2019 from the administrators for only £1.8m. More on the Investor's Champion website. | energeticbacker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions